Hunan Jiudian Pharmaceutical Co Ltd Asset Resilience Ratio
Hunan Jiudian Pharmaceutical Co Ltd asset resilience ratio. Hunan Jiudian Pharmaceutical Co Ltd (300705) has an Asset Resilience Ratio of 1.68% as of June 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See Hunan Jiudian Pharmaceutical Co Ltd liquidity coverage in days to measure how many days the company can operate on defensive assets alone.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio of Hunan Jiudian Pharmaceutical Co Ltd (2021–2025)
Asset resilience ratio of Hunan Jiudian Pharmaceutical Co Ltd from 2021 to 2025. This chart shows how Hunan Jiudian Pharmaceutical Co Ltd's Asset Resilience Ratio has changed over time. Read Hunan Jiudian Pharmaceutical Co Ltd (300705) financial obligations for a breakdown of total debt and financial obligations.
Liquid Assets Composition Over Time
This chart breaks down Hunan Jiudian Pharmaceutical Co Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see how large is Hunan Jiudian Pharmaceutical Co Ltd's balance sheet.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CN¥0.00 | 0% |
| Short-term Investments | CN¥70.04 Million | 1.68% |
| Total Liquid Assets | CN¥70.04 Million | 1.68% |
Asset Resilience Insights
- Limited Liquidity: Hunan Jiudian Pharmaceutical Co Ltd maintains only 1.68% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
Hunan Jiudian Pharmaceutical Co Ltd Industry Peers by Asset Resilience Ratio
Compare Hunan Jiudian Pharmaceutical Co Ltd's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Jiangsu Hengrui Medicine Co Ltd
SHG:600276 |
Drug Manufacturers - Specialty & Generic | 0.16% |
|
Sandoz Group AG
SW:SDZ |
Drug Manufacturers - Specialty & Generic | 7.89% |
|
H Lundbeck A/S
CO:HLUN-B |
Drug Manufacturers - Specialty & Generic | -0.56% |
|
Changchun High & New Technology Industries Group Inc
SHE:000661 |
Drug Manufacturers - Specialty & Generic | 5.50% |
|
Hubei Jumpcan Pharmaceutical Co Ltd
SHG:600566 |
Drug Manufacturers - Specialty & Generic | 47.16% |
|
Kangmei Pharmaceutical Co Ltd
SHG:600518 |
Drug Manufacturers - Specialty & Generic | 0.00% |
|
Viyash Scientific Limited
NSE:SEQUENT |
Drug Manufacturers - Specialty & Generic | 0.08% |
|
Anhui Fengyuan Pharmaceutical Co Ltd
SHE:000153 |
Drug Manufacturers - Specialty & Generic | 1.81% |
Hunan Jiudian Pharmaceutical Co Ltd Asset Resilience Ratio by Year (2021–2025)
Hunan Jiudian Pharmaceutical Co Ltd asset resilience ratio by year from 2021 to 2025. The table below shows the annual Asset Resilience Ratio data for Hunan Jiudian Pharmaceutical Co Ltd.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2025-12-31 | 4.01% | CN¥161.29 Million ≈ $23.60 Million |
CN¥4.02 Billion ≈ $588.08 Million |
-3.72pp |
| 2024-12-31 | 7.73% | CN¥260.71 Million ≈ $38.15 Million |
CN¥3.37 Billion ≈ $493.60 Million |
+4.58pp |
| 2023-12-31 | 3.14% | CN¥90.29 Million ≈ $13.21 Million |
CN¥2.87 Billion ≈ $420.15 Million |
-0.78pp |
| 2022-12-31 | 3.92% | CN¥90.26 Million ≈ $13.21 Million |
CN¥2.30 Billion ≈ $336.51 Million |
-1.82pp |
| 2021-12-31 | 5.75% | CN¥100.31 Million ≈ $14.68 Million |
CN¥1.75 Billion ≈ $255.38 Million |
-- |
About Hunan Jiudian Pharmaceutical Co Ltd
Hunan Jiudian Pharmaceutical Co., Ltd. researches, develops, produces, and sells pharmaceutical products in China and internationally. The company offers chemical drug preparations, active pharmaceutical ingredients (APIs), pharmaceutical excipients, traditional Chinese medicine, health foods, and rehabilitation and wellness products. Its products portfolio includes loxoprofen sodium gel patches,… Read more